Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, Reuters cited the US drugmaker as saying. The company said it had offered India a not-for-profit price for its vaccine for the government’s immunisation programme.
Last week, the Indian government said it would fast-track emergency approvals for foreign-made COVID-19 vaccines, a move that would exempt companies from carrying out “bridging” trials for their vaccines. The company said it ‘continues to be in discussions’ with the government, and remains “committed” to make the vaccine available for deployment in the country’s vaccination program. Meanwhile, Johnson & Johnson has said that it is seeking to conduct a local clinical trial in India for its single-dose COVID-19 vaccine. India is grappling with a massive surge in covid cases that has severely strained its health system and caused shortages of oxygen and medicines.